Track your shipment

Cell & Gene Therapy

Cell & Gene Control Towers

In four strategic locations across the globe, Marken’s state-of-the-art monitoring facilities provide full visibility of all cell and gene therapy shipments anywhere in the world. The Cell and Gene Control Tower is Marken’s latest service investment to further enhance our ability to provide flawless execution and expert support for these ultra-sensitive shipments.

Our Cell Therapy Management features state-of-the-art monitoring facilities providing visibility of your therapy shipments, globally.

Our Cell and Gene Control Center offers 24/7/365 visibility into cell and gene therapy shipments, enabling improved chain of custody and enhanced quality control to ensure sites and patients are receiving these medicines in an efficient and timely manner.

Our dedicated staff of cell and gene supply chain experts will monitor weather, flight delays, and other potential risks to make critical path decisions and ensure flawless execution of every shipment. Combined with our global network of liquid nitrogen storage facilities and fourteen designated Centers of Excellence for cell and gene therapy logistics across the U.S., Europe, and Asia, Marken’s facilities are strategically located to complete an end-to-end cell and gene therapy supply chain service for our clients.

Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss your cell therapy management needs. Contact us on +1-800-627-5361 (US) or email info@marken.com

Related resources

Mastering the Advanced Therapy Supply Chain

29 October 2024

The field of Advanced Therapy Medicinal Products (ATMPs) has seen monumental advancements in recent years, offering groundbreaking treatments for a…

Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 2

20 September 2024

Part 2 of our Orchestrating Outcomes for Logistics interview series highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation

Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 1

20 September 2024

To drive supply chain digitalization, it’s essential to leverage data not only to address immediate challenges but to anticipate and prevent disruptions

Marken Delivers Life-Saving Gene Therapy Treatment Over 3,000 Miles From Germany to the UAE in Under 48 Hours

18 September 2024

Marken was tasked with delivering a life-saving gene therapy treatment for a child suffering from Duchenne muscular dystrophy (DMD) in…

Marken seamlessly orchestrates distribution of first commercial CAR-T therapy drug product from USA to Japan

17 October 2023

Marken successfully orchestrated the distribution of the first commercial CAR-T therapy drug product from the USA to a hospital in…

Marken’s 24/7 Cell & Gene Control Tower Provides Agile Solution for Critical Shipments

9 February 2023

Marken’s Cell and Gene Control Tower re-routed six critical shipments of CAR-T drug products from Amsterdam to the UK and…

Operational Excellence Overcomes Obstacles to Deliver Critical Autologous Cell Therapy

9 February 2023

Marken utilized operational excellence to deliver a critical autologous cell therapy. Although there were many challenges, Marken was able to…

Marken Successfully Safeguards the Viability of Pharmaceutical Samples Within 42 Hours

4 January 2023

The distribution of critical cell samples requires an agile strategy with contingency planning and regulatory expertise to ensure seamless delivery…

Happy Holidays from Marken

21 December 2022

At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…

Marken Overcomes Multiple Obstacles To Successfully Deliver Critical Stem Cell Samples Across The Globe

9 December 2022

Stem cell samples require extremely tight 24-hour turnaround times in order to be modified and processed for critical cell therapy…

The Complex Demands of Personalized Medicine Supply Chains.

26 July 2021

Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved…

Evaluating a Clinical Supply Chain Partner to Meet Your Vaccine Trial Needs.

23 April 2021

It is essential for pharmaceutical companies to evaluate many factors when choosing a clinical supply chain partner. With today’s global…

View more
Marken Logo

Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.

Track your shipment